Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Adatia

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 6, 2021
Underestimation of airway luminal eosinophilia by quantitative sputum cytometryMelanie Kjarsgaard, Adil Adatia, Anurag Bhalla, et al.
ERJ Open Research|December 2, 2020
Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?Imran Satia, Adil Adatia, Sarah Yaqoob, et al.
ERJ Open Research|May 28, 2021
Influence of age, sex and respiratory viruses on the rates of emergency department visits and hospitalisations with respiratory tract infections, asthma and COPDImran Satia, Adil Adatia, Ruth P Cusack, et al.
Journal of Clinical Medicine|July 13, 2024
Upper Airway Alarmin Cytokine Expression in Asthma of Different SeveritiesHazel Marriott, Marc Duchesne, Subhabrata Moitra, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The World Allergy Organization Journal|December 1, 2025
A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedemaDaniel K Lee, Arije Ghannam, Nivetha Murugesan, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 8, 2026
Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbationsSarita Thawanaphong, Lucia Gonzalez-Bravo, Katherine Radford, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 30, 2019
Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis CohortSofianne Gabrielli, Ann Clarke, Judy Morris, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 8, 2025
Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in CanadaSusan Waserman, Gina Lacuesta, Amin S Kanani, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 6, 2021
Underestimation of airway luminal eosinophilia by quantitative sputum cytometryMelanie Kjarsgaard, Adil Adatia, Anurag Bhalla, et al.
ERJ Open Research|December 2, 2020
Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?Imran Satia, Adil Adatia, Sarah Yaqoob, et al.
ERJ Open Research|May 28, 2021
Influence of age, sex and respiratory viruses on the rates of emergency department visits and hospitalisations with respiratory tract infections, asthma and COPDImran Satia, Adil Adatia, Ruth P Cusack, et al.
Journal of Clinical Medicine|July 13, 2024
Upper Airway Alarmin Cytokine Expression in Asthma of Different SeveritiesHazel Marriott, Marc Duchesne, Subhabrata Moitra, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 28, 2024
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in CanadaAdil Adatia, Jean-Nicolas Boursiquot, Dawn Goodyear, et al.
The World Allergy Organization Journal|December 1, 2025
A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedemaDaniel K Lee, Arije Ghannam, Nivetha Murugesan, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 8, 2026
Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbationsSarita Thawanaphong, Lucia Gonzalez-Bravo, Katherine Radford, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 30, 2019
Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis CohortSofianne Gabrielli, Ann Clarke, Judy Morris, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 8, 2025
Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in CanadaSusan Waserman, Gina Lacuesta, Amin S Kanani, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
Pageof 4